Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study

医学 不良事件通用术语标准 低温消融 回顾性队列研究 阶段(地层学) 累积发病率 间质性肺病 四分位间距 肺癌 不利影响 危险系数 队列 外科 内科学 置信区间 烧蚀 古生物学 生物
作者
Jonathan A. Sänger,Alexander Graur,Ismail Tahir,Melissa C. Price,Florence K. Keane,Michael Lanuti,Amita Sharma,Florian J. Fintelmann
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:181: 107231-107231 被引量:10
标识
DOI:10.1016/j.lungcan.2023.107231
摘要

To compare the safety and efficacy of cryoablation of treatment-naïve stage IA non-small cell lung cancer (NSCLC) in patients with and without interstitial lung disease (ILD).This retrospective single-center cohort study evaluated 33 consecutive patients (24 females, median age 75 years, Eastern Cooperative Oncology Group performance score 0-3) with ILD (9 patients) and without ILD (24 patients) who underwent 39 percutaneous cryoablations to treat 42 stage IA (8th IASLC edition) NSCLC measuring 1.2 cm (range 0.5-2.6 cm) from 2018 to 2022. Presence of ILD was determined according to 2018 American Thoracic Society Criteria on pre-ablation CT scans. The primary outcome was 90-day adverse events graded by the Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Secondary outcomes were hospital length of stay (LOS), local recurrence-free survival, overall survival, and the cumulative incidence of local recurrence with death as a competing risk.Adverse events ranged from grade 1-3 and occurred more often in the non-ILD group (p <.001). No acute exacerbation of ILD or death occurred within 90 days after cryoablation. The median LOS was 1 day (interquartile range 1-2 days) and did not differ between groups. One patient with ILD and two patients without ILD died after 22, 26, and 27 months from causes unrelated to cryoablation. Median imaging follow-up was 11 months (range, 0-47 months) and three tumors (7%) showed local recurrence after 4, 17, and 22 months. No difference in the cumulative incidence of local recurrence (p =.56) was found. Among all patients, local recurrence-free survival on a per-tumor basis and overall survival were 97% and 100% at 1 year, respectively.Adverse events and local recurrence following percutaneous cryoablation of stage IA NSCLC did not differ between patients with and without ILD. No acute exacerbation of ILD or death within 90 days were observed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
情怀应助SherlockHe采纳,获得10
1秒前
1秒前
3秒前
LJJ发布了新的文献求助10
4秒前
百十余发布了新的文献求助10
5秒前
7秒前
Neo完成签到,获得积分10
7秒前
slr发布了新的文献求助10
8秒前
freeaway完成签到 ,获得积分10
8秒前
8秒前
9秒前
俊秀的卿发布了新的文献求助10
10秒前
量子星尘发布了新的文献求助10
10秒前
8R60d8应助xiaosu采纳,获得10
12秒前
liii发布了新的文献求助10
13秒前
momo发布了新的文献求助10
14秒前
赘婿应助Fengliguantou采纳,获得10
16秒前
不安的紫翠完成签到,获得积分10
18秒前
魁梧的鲂完成签到,获得积分10
19秒前
21秒前
华仔应助momo采纳,获得10
21秒前
隐形的糖豆完成签到,获得积分10
22秒前
qjq琪完成签到 ,获得积分10
22秒前
23秒前
24秒前
魁梧的鲂发布了新的文献求助10
25秒前
25秒前
26秒前
Lucas应助ysy采纳,获得10
27秒前
诚心的扬完成签到 ,获得积分10
27秒前
苗条梦玉发布了新的文献求助10
28秒前
cjdsb发布了新的文献求助10
28秒前
传奇3应助奋斗夏烟采纳,获得10
29秒前
30秒前
脑洞疼应助LW采纳,获得30
30秒前
33秒前
34秒前
妮妮完成签到,获得积分10
34秒前
36秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989334
求助须知:如何正确求助?哪些是违规求助? 3531428
关于积分的说明 11253936
捐赠科研通 3270119
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173